NO161258C - Analogifremgangsm te til fremstilling av terapeutisk aktive 1-pyridyloksy-3-indolylalkylamino-2-propanol-derivater. - Google Patents

Analogifremgangsm te til fremstilling av terapeutisk aktive 1-pyridyloksy-3-indolylalkylamino-2-propanol-derivater.

Info

Publication number
NO161258C
NO161258C NO833128A NO833128A NO161258C NO 161258 C NO161258 C NO 161258C NO 833128 A NO833128 A NO 833128A NO 833128 A NO833128 A NO 833128A NO 161258 C NO161258 C NO 161258C
Authority
NO
Norway
Prior art keywords
indolylalkylamino
pyridyloxy
preparation
therapeutic active
analogy procedure
Prior art date
Application number
NO833128A
Other languages
English (en)
Other versions
NO833128L (no
NO161258B (no
Inventor
William E Kreighbaum
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NO833128L publication Critical patent/NO833128L/no
Priority to NO873819A priority Critical patent/NO170329C/no
Publication of NO161258B publication Critical patent/NO161258B/no
Publication of NO161258C publication Critical patent/NO161258C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO833128A 1982-09-03 1983-09-01 Analogifremgangsm te til fremstilling av terapeutisk aktive 1-pyridyloksy-3-indolylalkylamino-2-propanol-derivater. NO161258C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO873819A NO170329C (no) 1982-09-03 1987-09-14 Substituert propanol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41474882A 1982-09-03 1982-09-03

Publications (3)

Publication Number Publication Date
NO833128L NO833128L (no) 1984-03-05
NO161258B NO161258B (no) 1989-04-17
NO161258C true NO161258C (no) 1989-07-26

Family

ID=23642783

Family Applications (1)

Application Number Title Priority Date Filing Date
NO833128A NO161258C (no) 1982-09-03 1983-09-01 Analogifremgangsm te til fremstilling av terapeutisk aktive 1-pyridyloksy-3-indolylalkylamino-2-propanol-derivater.

Country Status (28)

Country Link
JP (1) JPS5965087A (no)
KR (1) KR870001019B1 (no)
AT (1) AT387385B (no)
AU (4) AU567112B2 (no)
BE (1) BE897671A (no)
CA (1) CA1236834A (no)
CH (2) CH668593A5 (no)
CY (1) CY1521A (no)
DE (1) DE3331612A1 (no)
DK (1) DK399783A (no)
ES (4) ES525243A0 (no)
FI (1) FI79709C (no)
FR (1) FR2543952B1 (no)
GB (1) GB2126230B (no)
GR (1) GR79061B (no)
HK (1) HK17490A (no)
HU (2) HU194164B (no)
IE (1) IE56201B1 (no)
IL (1) IL69618A (no)
IT (1) IT1169459B (no)
LU (1) LU84986A1 (no)
NL (1) NL8303038A (no)
NO (1) NO161258C (no)
NZ (1) NZ205466A (no)
PT (1) PT77282B (no)
SE (2) SE460419B (no)
YU (2) YU45150B (no)
ZA (1) ZA836469B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2543952B1 (fr) * 1982-09-03 1986-02-21 Bristol Myers Co Composes hydrocarbones heterocycliques appartenant aux series indoliques et leur application pharmacologique
DE3721260A1 (de) * 1987-06-27 1989-01-12 Beiersdorf Ag Neue indolylpropanole, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
US5030640A (en) * 1989-01-05 1991-07-09 Merck & Co., Inc. Novel β-adrenergic agonists and pharmaceutical compositions thereof
BR0114884A (pt) * 2000-10-25 2004-07-06 Smithkline Beecham Corp Compostos calcilìticos
KR100457857B1 (ko) * 2002-05-23 2004-11-18 (주) 비엔씨바이오팜 2-[2-(3-인돌릴)에틸아미노]피리딘 유도체, 그 제조방법및 이를 포함하는 항바이러스용 약학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144343A (en) * 1978-01-04 1979-03-13 Merck & Co., Inc. Heterocycle substituted (3-loweralkylamino-2-R1 O-propoxy)pyridines
FR2463765A1 (fr) * 1979-08-17 1981-02-27 Clin Midy Nouveaux derives de l'indole actifs sur le systeme cardiovasculaire
FR2543952B1 (fr) * 1982-09-03 1986-02-21 Bristol Myers Co Composes hydrocarbones heterocycliques appartenant aux series indoliques et leur application pharmacologique
CA1241660A (en) * 1984-06-25 1988-09-06 Yvan Guindon Indole-2-alkanoic acids

Also Published As

Publication number Publication date
DE3331612A1 (de) 1984-03-08
AU567112B2 (en) 1987-11-12
AU1859283A (en) 1984-03-08
YU224786A (en) 1987-10-31
CY1521A (en) 1990-11-16
YU44940B (en) 1991-04-30
ES8604930A1 (es) 1986-02-16
KR840006235A (ko) 1984-11-22
CA1236834A (en) 1988-05-17
SE460419B (sv) 1989-10-09
IE832063L (en) 1984-03-03
FI833102A (fi) 1984-03-04
GB2126230A (en) 1984-03-21
AU613589B2 (en) 1991-08-08
AU8055887A (en) 1988-02-18
AU8055787A (en) 1988-02-18
HK17490A (en) 1990-03-16
NL8303038A (nl) 1984-04-02
NZ205466A (en) 1986-12-05
NO833128L (no) 1984-03-05
SE8802265L (sv) 1988-06-16
FI833102A0 (fi) 1983-08-31
SE8304751L (sv) 1984-03-04
ES547111A0 (es) 1986-02-16
YU45150B (en) 1992-03-10
DK399783A (da) 1984-03-04
FR2543952B1 (fr) 1986-02-21
KR870001019B1 (ko) 1987-05-23
NO161258B (no) 1989-04-17
IT1169459B (it) 1987-05-27
PT77282B (en) 1986-04-28
HU192862B (en) 1987-07-28
ES547110A0 (es) 1986-02-16
SE8802265D0 (sv) 1988-06-16
IL69618A0 (en) 1983-12-30
ZA836469B (en) 1984-04-25
IL69618A (en) 1987-02-27
IT8322765A0 (it) 1983-09-02
AU609067B2 (en) 1991-04-26
PT77282A (en) 1983-10-01
SE8304751D0 (sv) 1983-09-02
IE56201B1 (en) 1991-05-22
BE897671A (fr) 1984-03-02
GB8323641D0 (en) 1983-10-05
JPS5965087A (ja) 1984-04-13
ES8507537A1 (es) 1985-09-01
ES8505200A1 (es) 1985-05-16
LU84986A1 (fr) 1984-04-24
AU8055987A (en) 1988-02-18
CH668593A5 (fr) 1989-01-13
FI79709B (fi) 1989-10-31
HU194164B (en) 1988-01-28
FI79709C (fi) 1990-02-12
YU180383A (en) 1988-06-30
ES531872A0 (es) 1985-05-16
FR2543952A1 (fr) 1984-10-12
CH661512A5 (fr) 1987-07-31
AU609068B2 (en) 1991-04-26
DK399783D0 (da) 1983-09-01
GB2126230B (en) 1987-01-14
ES8604931A1 (es) 1986-02-16
ATA315583A (de) 1988-06-15
ES525243A0 (es) 1985-09-01
AT387385B (de) 1989-01-10
GR79061B (no) 1984-10-02

Similar Documents

Publication Publication Date Title
NO158099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO162022C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive cefemderivater.
NO156864B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO159531C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
NO166327C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO165239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO152129C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO161676C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive mitosanderivater.
NO164168C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,7,4-triazolforbindelser.
NO159654C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 2-guanidin-4-heteroaryltiazolderivater.
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO161559C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO160079C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO155840C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive taurin-derivater.
NO158739C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO160511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.
NO160000C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser.
NO161177C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive tioetere.
NO168478C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater.
NO160512C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.